These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Melody transcatheter pulmonary valve implantation. Results from the registry of the Italian Society of Pediatric Cardiology. Butera G, Milanesi O, Spadoni I, Piazza L, Donti A, Ricci C, Agnoletti G, Pangrazi A, Chessa M, Carminati M. Catheter Cardiovasc Interv; 2013 Feb; 81(2):310-6. PubMed ID: 22718682 [Abstract] [Full Text] [Related]
4. Melody ® transcatheter pulmonary valve implantation: results from a French registry. Fraisse A, Aldebert P, Malekzadeh-Milani S, Thambo JB, Piéchaud JF, Aucoururier P, Chatelier G, Bonnet D, Iserin L, Bonello B, Assaidi A, Kammache I, Boudjemline Y. Arch Cardiovasc Dis; 2014 Nov; 107(11):607-14. PubMed ID: 25453718 [Abstract] [Full Text] [Related]
5. French national survey on infective endocarditis and the Melody™ valve in percutaneous pulmonary valve implantation. Malekzadeh-Milani S, Houeijeh A, Jalal Z, Hascoet S, Bakloul M, Aldebert P, Piéchaud JF, Heitz F, Bouvaist H, Dauphin C, Guérin P, Villemain O, Petit J, Godart F, Thambo JB, Boudjemline Y, French working group of Cardiac Catheterization in Congenital Heart Disease Patients. Arch Cardiovasc Dis; 2018 Nov; 111(8-9):497-506. PubMed ID: 29530718 [Abstract] [Full Text] [Related]
10. Infective Endocarditis Risk After Percutaneous Pulmonary Valve Implantation With the Melody and Sapien Valves. Hascoet S, Mauri L, Claude C, Fournier E, Lourtet J, Riou JY, Brenot P, Petit J. JACC Cardiovasc Interv; 2017 Mar 13; 10(5):510-517. PubMed ID: 28279319 [Abstract] [Full Text] [Related]
14. Stent fracture, valve dysfunction, and right ventricular outflow tract reintervention after transcatheter pulmonary valve implantation: patient-related and procedural risk factors in the US Melody Valve Trial. McElhinney DB, Cheatham JP, Jones TK, Lock JE, Vincent JA, Zahn EM, Hellenbrand WE. Circ Cardiovasc Interv; 2011 Dec 01; 4(6):602-14. PubMed ID: 22075927 [Abstract] [Full Text] [Related]
15. Clinical and hemodynamic outcomes up to 7 years after transcatheter pulmonary valve replacement in the US melody valve investigational device exemption trial. Cheatham JP, Hellenbrand WE, Zahn EM, Jones TK, Berman DP, Vincent JA, McElhinney DB. Circulation; 2015 Jun 02; 131(22):1960-70. PubMed ID: 25944758 [Abstract] [Full Text] [Related]
16. Use and performance of the Melody Transcatheter Pulmonary Valve in native and postsurgical, nonconduit right ventricular outflow tracts. Meadows JJ, Moore PM, Berman DP, Cheatham JP, Cheatham SL, Porras D, Gillespie MJ, Rome JJ, Zahn EM, McElhinney DB. Circ Cardiovasc Interv; 2014 Jun 02; 7(3):374-80. PubMed ID: 24867892 [Abstract] [Full Text] [Related]
18. Risk factors for infective endocarditis following transcatheter pulmonary valve replacement in patients with congenital heart disease. Sadeghi S, Wadia S, Lluri G, Tarabay J, Fernando A, Salem M, Sinha S, Levi DS, Aboulhosn J. Catheter Cardiovasc Interv; 2019 Oct 01; 94(4):625-635. PubMed ID: 31471941 [Abstract] [Full Text] [Related]